Houda Alachkar, PharmD, PhD
Assistant ProfessorClinical Pharmacy
- Experimental Cancer Therapeutics
- Acute Myeloid Leukemia
Clinical Pharmacology and Pharmacogenomics Fellowship, The Univesity of Chicago
Ph.D., The Ohio State University
PharmD, Ohio Northern University
M.S., Wright State University
B.S., Pharmacy, University of Aleppo
The revolution in sequencing technologies has given the momentum for the emerging genomics and personalized medicine era that led to great discoveries, particularly in cancer research. Translating these findings into the clinic, however, has moved at a much slower pace. It is evident that cancer pharmacogenomic variation, the somatic changes in cancer cells and germline variants in normal cells, influence the disease outcome and response to treatment.
The Alachkar lab focuses on applying genomic information to the identification and functional characterization of cancer targets, and in the preclinical and clinical developments of potential targeted therapeutic approaches with particular interest in acute myeloid leukemia.
Dr. Houda Alachkar received her Ph.D. in Biomedical Sciences from the Ohio State University in December 2012 under the mentorship of Prof. Guido Marcucci and received her PharmD degree from Ohio Northern University in 2011. She completed a fellowship in Clinical Pharmacology and Pharmacogenomics at the University of Chicago in 2015 under the mentorship of Prof. Yusuke Nakamura and Prof. Wendy Stock. In September 2015, she joined the University of Southern California (USC) School of Pharmacy as an Assistant Professor.
Dr. Alachkar's translational research focuses on cancer therapeutics and pharmacogenomics, particularly in acute myeloid leukemia.